The Ras Inhibitor Farnesylthiosalicylic Acid as a Potential Therapy for Neurofibromatosis Type 1Batya Barkan(Tel Aviv University), Yoel Kloog(Tel Aviv University)Clinical Cancer ResearchSeptember 15, 200610.1158/1078-0432.ccr-06-0792Cited by 69SaveCiteExport RISWatch citationsRelated PapersNovel LIMK2 inhibitor blocks Panc-1 tumor growth in a mouse xenograft model|Oncoscience|2014|31Ras inhibition boosts galectin-7 at the expense of galectin-1 to sensitize cells to apoptosis|Oncotarget|2013|27